# AIDS 347: IL-6 Blockade in Treated HIV Infection

> **NCT02049437** · PHASE1,PHASE2 · COMPLETED · sponsor: **Case Western Reserve University** · enrollment: 34 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** tocilizumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02049437
- **Lead sponsor:** Case Western Reserve University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2017-09-11
- **Final completion:** 2017-09-11
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2024-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02049437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02049437, "AIDS 347: IL-6 Blockade in Treated HIV Infection". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02049437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*